While patients with active psoriasis and low disease activity (LDA) in psoriatic arthritis (DAPSA-LDA) have generally good health-related quality of life, some still experience impacts to quality of life, according to a study published in Clinical and Experimental Rheumatology.
Researchers analyzed patients who reached DAPSA-LDA at 1 year of follow-up. Of these patients, 44% (n = 230) had DAPSA-LDA at baseline, 47% of whom achieved psoriasis remission. In the those with active psoriasis, 31% experienced moderate-to-high impairment as assessed by a symptom subscale and 28% experienced considerable symptoms.
The investigators recommended that rheumatologists continue to assess and treat patients with psoriasis who achieved musculoskeletal LDA to ameliorate skin burden.
Reference: Kasiem FR, Kok MR, Luime JJ, et al. Impact of psoriasis remains important in psoriatic arthritis patients with low musculoskeletal disease activity. Clin Exp Rheumatol. 2022. doi:10.55563/clinexprheumatol/q8fh0a
